Who owns Acorda Therapeutics?

Key details on Acorda Therapeutics (Ticker: ACOR)

Who owns Acorda Therapeutics?

Is ACOR a good stock to own? Find out who bought Acorda Therapeutics, who sold Acorda Therapeutics (ACOR) stock, and who holds a large position in Acorda Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 6.39M $212.54M March 31, 2015
BlackRock Fund Advisors 3.00M $99.95M March 31, 2015
Vanguard 2.99M $99.34M March 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.89M $96.09M March 31, 2015
Adage Capital Partners GP 2.71M $64.60M Dec. 31, 2011
Damian Sousa 2.46M $81.93M March 31, 2015
Wellington Management Company 1.93M $64.21M March 31, 2015
Oracle Investment Management 1.85M $62.71M Sept. 30, 2014
Invus Public Equities Advisors 1.70M $54.93M June 30, 2011
Artal Group S.A. 1.50M $49.48M June 30, 2013
Bridger Management 1.50M $39.83M March 31, 2012
GOLDMAN SACHS 1.49M $43.60M Dec. 31, 2013
STATE STREET CORPORATION 1.41M $46.82M March 31, 2015
Ulys 1.30M $34.52M March 31, 2012
Inves 1.25M $47.48M March 31, 2014
Partner Fund Management 1.23M $41.54M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 1.21M $40.18M March 31, 2015
Camber Capital Management 1.20M $28.61M Dec. 31, 2011

Who sold Acorda Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
S.A.C. Capital Advisors June 30, 2011 2.36M $76.31M
Brookside Capital Management, LLC* June 30, 2011 1.39M $44.78M
Wells Fargo & Company March 31, 2011 2.34M $53.62M
Millennium Management March 31, 2011 1.35M $31.36M
Westfield Capital Management Company Dec. 31, 2010 1.77M $48.24M
Senator Investment Dec. 31, 2010 1.23M $33.39M
Columbia Wanger Asset Management Sept. 30, 2010 2.06M $68.09M